glp-1 and liver Receptor Agonists in Non-Alcoholic Fatty Disease: Current Evidence Future Perspectives GLP‑1 Liver Disease: New MASLD

The Semaglutide Weight Loss Program is a clinician-guided telehealth program built around compounded semaglutide, a GLP-1 medication that supports appetite control, quiets food noise, and makes a calorie deficit easier to sustain

Blood tests can check for thyroid dysfunction or markers of infection

bmj 352 (2016)

Discuss with your provider whether the additional weight loss justifies the higher dose, or whether maintaining at the plateau weight with the current dose is the more appropriate goal

Using advanced, time-released technology, the patch delivers a powerful blend of natural ingredients like Berberine and L-Carnitine to naturally support the body's own GLP-1 hormone